There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Ischemia-reperfusion injury (I/R) has a negative effect on renal allograft survival.
Using a rat model of kidney IR injury, we demonstrated inhibition of Toll-like receptor
(TLR) 4 with erotoran may shed new light on I/R therapy.